Cargando…

The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques

BACKGROUND: Our research compared whole pelvic (WP) and prostate-only (PO) 3-dimensional conformal radiotherapy (3DCRT) techniques in terms of the incidence and evolution of acute and late toxicity of the rectum and urinary bladder, and identified the PTV-parameters influencing these damages and cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vranova, Jana, Vinakurau, Stepan, Richter, Jan, Starec, Miroslav, Fiserova, Anna, Rosina, Jozef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162893/ https://www.ncbi.nlm.nih.gov/pubmed/21794152 http://dx.doi.org/10.1186/1748-717X-6-87

Ejemplares similares

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
por: Sanguineti, G, et al.
Publicado: (2002)

Strategies to evaluate the impact of rectal volume on prostate motion during three-dimensional conformal radiotherapy for prostate cancer
por: Poli, Ana Paula Diniz Fortuna, et al.
Publicado: (2016)

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose
por: Ong, Ashley Li Kuan, et al.
Publicado: (2022)

Dosimetric Comparison between Intensity Modulated Radiotherapy and 3 Dimensional Conformal Radiotherapy in the Treatment of Rectal Cancer
por: Simson, David K, et al.
Publicado: (2016)

Nomogram to predict rectal toxicity following prostate cancer radiotherapy
por: Delobel, Jean-Bernard, et al.
Publicado: (2017)

Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis
por: Onal, Cem, et al.
Publicado: (2009)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer
por: Yu, Mina, et al.
Publicado: (2013)

A Retrospective Comparison of Toxicity, Response and Survival of Intensity-Modulated Radiotherapy Versus Three-Dimensional Conformal Radiation Therapy in the Treatment of Rectal Carcinoma
por: Kouklidis, Georgios, et al.
Publicado: (2023)

Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy
por: Shelley, Leila E.A., et al.
Publicado: (2020)

Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer
por: Lu, Ning-Ning, et al.
Publicado: (2015)

Comparative Analysis of Efficacy, Toxicity, and Patient-Reported Outcomes in Rectal Cancer Patients Undergoing Preoperative 3D Conformal Radiotherapy or VMAT
por: Regnier, Antonia, et al.
Publicado: (2017)

A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2016)

Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost
por: Kapoor, Rakesh, et al.
Publicado: (2016)

Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis
por: Di Franco, Rossella, et al.
Publicado: (2017)

Minimal Rectal Toxicity in the Setting of Comorbid Crohn’s Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer
por: Singh, Raj, et al.
Publicado: (2017)

Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
por: Bae, Bong Kyung, et al.
Publicado: (2017)

Rectal retractor in prostate radiotherapy: pros and cons
por: Ghaffari, Hamed, et al.
Publicado: (2022)

The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain
por: Indrová, Marie, et al.
Publicado: (2018)

Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy
por: Shelley, L.E.A., et al.
Publicado: (2017)

Planning With Patient-Specific Rectal Sub-Region Constraints Decreases Probability of Toxicity in Prostate Cancer Radiotherapy
por: Lafond, Caroline, et al.
Publicado: (2020)

Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer
por: Tøndel, Hanne, et al.
Publicado: (2019)

Pencil‐beam scanning proton therapy for the treatment of glomus jugulare tumours
por: Kubeš, Jiří, et al.
Publicado: (2022)

Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy
por: Dröge, Leif Hendrik, et al.
Publicado: (2015)

Intra-rectal use of epinephrine in radiotherapy of prostate cancer
por: Qin, Shang-Bin, et al.
Publicado: (2019)

Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity
por: Haefner, Matthias Felix, et al.
Publicado: (2017)

The Three Dimensional Conformal Radiotherapy for Hyperkeratotic Plantar Mycosis Fungoides
por: Lee, Sun Young, et al.
Publicado: (2011)

Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities
por: Chen, Nai-Bin, et al.
Publicado: (2020)

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?
por: Liu, X, et al.
Publicado: (2018)

Clinical effects of rectal retractor application in prostate cancer radiotherapy
por: Arefpour, Amir Mohammad, et al.
Publicado: (2021)

A Retrospective Analysis of Dose Distribution and Toxicity in Patients with Left Breast Cancer Treated with Adjuvant Intensity-Modulated Radiotherapy: Comparison with Three-Dimensional Conformal Radiotherapy
por: Chen, Chia-Hsin, et al.
Publicado: (2020)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Metabolism and toxicity of 2,2,2-trifluoroethyl vinyl ether.
por: Fiserova-Bergerova, V
Publicado: (1977)

Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer
por: Yu, Mina, et al.
Publicado: (2013)

Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy
por: Kinhikar, Rajesh Ashok, et al.
Publicado: (2015)

Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices
por: Wilton, Lee, et al.
Publicado: (2017)

Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy
por: Cho, Jae Ho, et al.
Publicado: (2009)

Interfraction Prostate Movement in Bone Alignment After Rectal Enema for Radiotherapy
por: Seo, Young Eun, et al.
Publicado: (2014)

Incidental irradiation of internal mammary lymph nodes in breast cancer: conventional two-dimensional radiotherapy versus conformal three-dimensional radiotherapy
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2016)

Dosimetric comparison and observation of three-dimensional conformal radiotherapy for recurrent nasopharyngeal carcinoma
por: Pan, Rongqiang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ls607jfjsv4u84n9h0t2jeql25